Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,670 | -7,649 | -25,231 | -26,608 | -17,857 |
| Depreciation Amortization | 188 | 330 | 388 | 433 | 174 |
| Accounts payable and accrued liabilities | -758 | -850 | -270 | 2,133 | -60 |
| Other Working Capital | 262 | -2,695 | -276 | 3,077 | 380 |
| Other Operating Activity | 13,284 | -1,430 | 1,870 | -685 | 2,942 |
| Operating Cash Flow | $-19,694 | $-12,294 | $-23,519 | $-21,650 | $-14,421 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,555 | -1,555 |
| PPE Investments | -186 | -11 | -131 | -738 | -354 |
| Investing Cash Flow | $-186 | $-11 | $-131 | $817 | $-1,909 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 33,101 | 50,145 | N/A | 29,006 | 34,305 |
| Common Stock Repurchased | -1,668 | -380 | N/A | N/A | N/A |
| Financing Cash Flow | $31,433 | $49,765 | $N/A | $29,006 | $34,305 |
| Beginning Cash Position | 48,839 | 11,379 | 35,029 | 26,856 | 8,881 |
| End Cash Position | 60,392 | 48,839 | 11,379 | 35,029 | 26,856 |
| Net Cash Flow | $11,553 | $37,460 | $-23,650 | $8,173 | $17,975 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,694 | -12,294 | -23,519 | -21,650 | -14,421 |
| Capital Expenditure | -186 | -11 | -132 | -738 | -354 |
| Free Cash Flow | -19,880 | -12,305 | -23,651 | -22,388 | -14,775 |